Legal Disclaimer
Whilst ESI will endeavour to make reasonable efforts to keep the information contained on its web site current and accurate, it will not be responsible for any loss or damage of any nature whatsoever arising due to errors, omissions, or inaccuracies in the information provided.
Product development involves a high degree of risk and only a small number of research and development programs result in the commercialisation of a product. Success in preclinical and early clinical trials does not ensure that ESI will be successful in its efforts to develop and commercialise new products.
This web site contains forward looking statements. Such statements are subject to certain factors which may cause ESI’s plans to differ or results to vary from those expected These factors include, among other items, risks associated with the inherent uncertainty of biotechnology research, product development, clinical research, seeking regulatory approval and product commercialisation, as well as the impact of competitive products, patents, product liability and third-party reimbursement risks associated with the pharmaceutical industry.
ESI undertakes no obligation to publicly release or update the results of any of these forward looking statements which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Privacy
ESI is committed to protecting the identity and privacy of its web site users. ESI will only use personal information provided for the purposes for which it was collected (i.e. information request, distribution list subscription), and does not intend to disclose a user’s personal information to any third parties.
Links
ESI’s web site contains links to sites operated by other organisations. ESI is not responsible for the privacy practices of these other sites and encourages users to be aware of when they leave ESI’s site, and to read the privacy statements associated with any new site.
Copyright
This web site is owned by ES Cell International Pte Ltd (ESI). To reproduce, republish, distribute or display the content for any other purpose other than personal use, you must first obtain ESI’s express written permission.